Neutropenia Prediction Based on First-Cycle Blood Counts Using a FOS-3NN Classifier

Background. Delivery of full doses of adjuvant chemotherapy on schedule is key to optimal breast cancer outcomes. Neutropenia is a serious complication of chemotherapy and a common barrier to this goal, leading to dose reductions or delays in treatment. While past research has observed correlations...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirdel, Elize A., Korenberg, Michael J., Madarnas, Yolanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290820/
https://www.ncbi.nlm.nih.gov/pubmed/22454638
http://dx.doi.org/10.1155/2011/172615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290820/
https://www.ncbi.nlm.nih.gov/pubmed/22454638
http://dx.doi.org/10.1155/2011/172615

Ejemplares similares